• Dr. M. Sai Sashank is a highly skilled and experienced pulmonologist specializing in the diagnosis and treatment of respiratory disorders. With over 9 years of expertise in pulmonology, he has been at the forefront of managing complex lung diseases, including asthma, COPD, tuberculosis, interstitial lung diseases, and sleep-related breathing disorders.
• Dr. Sashank is known for his patient-centric approach and evidence-based treatments, ensuring comprehensive respiratory care. Currently practicing at TX Hospitals, Uppal, Hyderabad, he has a strong background in interventional pulmonology, allergic disorders, and sleep medicine. His dedication to advancing pulmonology is evident in his clinical experience, research contributions, and commitment to patient well-being.

Treatments & Conditions

• Asthma & COPD Management
• Pulmonary Infections (Pneumonia, Tuberculosis)
• Sleep Apnea & Sleep Disorders
• Chronic Bronchitis & Emphysema
• Interstitial Lung Disease
• Pulmonary Fibrosis
• Bronchogenic Carcinoma
• Smoking Cessation Programs
• Bronchoscopy & Interventional Procedures
• Allergy-related Pulmonary Disorders

Experience

• Consultant Pulmonologist – TX Hospitals, Uppal (Currently working)
• Former Consultant Pulmonologist – Sashanks Chest and Allergy Clinic, Peerzadiguda
• Former Consultant Pulmonologist – Medisys Hospitals (Sep 2020 – Aug 2022)
• Former Consultant Pulmonologist – Bhrungi Hospitals, B.N. Reddy

• Pulmonology
• Chest Medicine
• Interventional Pulmonology
• Respiratory Medicine
• Tuberculosis and Chest Diseases
• Sleep Medicine (Somnology)
• Allergy & Immunology

• Runner-up – Pulmonology Quiz, Kamineni Hospitals, South Zone CME-2019

Paper Presentation:

• Diagnostic Efficacy of Invasive vs. Non-Invasive Methods in Hemoptysis – TSTCCON 2019
• Patient Outcome After COPD Exacerbation Requiring Non-Invasive Ventilation – APSACON 2019

Research Publications:

• Diagnostic Efficacy of Bronchoscopy and CT-Guided Modalities in Bronchogenic Carcinoma – IOSR-JDMS
• Role of Tocilizumab in Combating Cytokine Storm in COVID-19 – JPRI
• Role of Cytosorb in Severe COVID-19 Patients – Global Journal